AstraZeneca: all 4,196 studies
Page 4 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCompletedNCT06644924Phase 2Results posted
- Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)CompletedNCT06578949Phase 3Results posted
- Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney DiseaseCompletedNCT06350123Phase 2Results posted
- A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled HypertensionCompletedNCT06336356Phase 2Results posted
- A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKCompletedNCT06269484Phase 2Results posted
- A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With AsthmaCompletedNCT06245551Phase 3Results posted
- A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With DyslipidemiaCompletedNCT06173570Phase 2Results posted
- A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant HypertensionCompletedNCT06168409Phase 3Results posted
- Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19CompletedNCT06057064Phase 2Results posted
- A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of NirsevimabCompletedNCT06042049Phase 3Results posted
- A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionCompletedNCT06034743Phase 3Results posted
- Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in ChinaCompletedNCT05886244Phase 3Results posted
- Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in ChinaCompletedNCT05876351Phase 3Results posted
- Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled AsthmaCompletedNCT05850494Phase 3Results posted
- A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisCompletedNCT05809934Phase 2Results posted
- A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)CompletedNCT05755906Phase 3Results posted
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKETerminatedNCT05746559Phase 3Results posted
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2CompletedNCT05737940Phase 2Results posted
- Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)CompletedNCT05648110Phase 2/3Results posted
- Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy ParticipantsCompletedNCT05641311Phase 1Results posted
- A Study in Participants With Non-cirrhotic NASH With FibrosisCompletedNCT05638737Phase 2Results posted
- A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.CompletedNCT05587998Phase 1Results posted
- A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT05573464Phase 3Results posted
- A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA PropellantCompletedNCT05569421Phase 1Results posted
- Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell DiseaseTerminatedNCT05565092Phase 2Results posted
- PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway ObstructionCompletedNCT05555290Phase 3Results posted
- BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory ImagingCompletedNCT05552508Phase 4Results posted
- Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)TerminatedNCT05516498Phase 2Results posted
- Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerCompletedNCT05498155Phase 2Results posted
- An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.CompletedNCT05492877Phase 2Results posted
- Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA PropellantCompletedNCT05477108Phase 1Results posted
- A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)Active, not recruitingNCT05460273Phase 1/2Results posted
- Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124CompletedNCT05459688Phase 2Results posted
- Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 MutationsActive, not recruitingNCT05457257Phase 4Results posted
- CARE FOR ALL:an Evaluation of an Asthma QIPCompletedNCT05440097Phase 4Results posted
- A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney DiseaseCompletedNCT05432167Phase 2Results posted
- Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaTerminatedNCT05398263Phase 3Results posted
- A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursTerminatedNCT05397171Phase 1/2Results posted
- Pharmacokinetic Study of Ravulizumab Administered Subcutaneously With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult VolunteersCompletedNCT05396742Phase 1Results posted
- FAsenra Safety Trial in IndiaCompletedNCT05384938Phase 4Results posted
- A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19TerminatedNCT05375760Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisCompletedNCT05364931Phase 2Results posted
- Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge StudyCompletedNCT05347693Phase 4Results posted
- Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesCompletedNCT05329194Phase 4Results posted
- A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy AdultsCompletedNCT05319912Phase 1Results posted
- A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy AdultsCompletedNCT05319899Phase 1Results posted
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNActive, not recruitingNCT05309668Phase 1/2Results posted
- Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1910 in Healthy ParticipantsCompletedNCT05307978Phase 1Results posted
- Study of Oral ALXN1840 at 2 Dose Strengths in Healthy AdultsCompletedNCT05303324Phase 1Results posted
- A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult ParticipantsCompletedNCT05288829Phase 1Results posted
- A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese ParticipantsCompletedNCT05288816Phase 1Results posted
- A Study of Multiple Doses of ALXN1210 in Healthy Adult ParticipantsCompletedNCT05288673Phase 1Results posted
- A Study of a Single Dose of ALXN1210 in Healthy ParticipantsCompletedNCT05288660Phase 1Results posted
- AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in PediatricsCompletedNCT05281601Phase 1Results posted
- Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCompletedNCT05274815Phase 3Results posted
- A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult ParticipantsTerminatedNCT05254613Phase 1Results posted
- Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)TerminatedNCT05251909Phase 3Results posted
- A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLCActive, not recruitingNCT05246514Phase 2Results posted
- AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With HypoparathyroidismCompletedNCT05239221Phase 1/2Results posted
- A Safety Study of AZD4041 in Healthy ParticipantsCompletedNCT05233085Phase 1Results posted
- Real-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS).CompletedNCT05219162Phase 4Results posted
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia GravisTerminatedNCT05218096Phase 2Results posted
- Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin LymphomaCompletedNCT05216835Phase 1Results posted
- Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCTerminatedNCT05215951Phase 2Results posted
- A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin LymphomaTerminatedNCT05205161Phase 1Results posted
- A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)CompletedNCT05202262Phase 3Results posted
- A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese AdultsCompletedNCT05184062Phase 2Results posted
- Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)Active, not recruitingNCT05171816Phase 3Results posted
- Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy ParticipantsCompletedNCT05166421Phase 1Results posted
- AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHLCompletedNCT05140382Phase 2Results posted
- A Study of CIN-107 in Patients With Uncontrolled HypertensionCompletedNCT05137002Phase 2Results posted
- Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast CancerActive, not recruitingNCT05113251Phase 3Results posted
- A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)Active, not recruitingNCT05104866Phase 3Results posted
- Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)TerminatedNCT05097989Phase 2Results posted
- Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaCompletedNCT05062759Phase 3Results posted
- A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 InhibitionActive, not recruitingNCT05061134Phase 2Results posted
- A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised AdultsTerminatedNCT05057897Phase 4Results posted
- A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTerminatedNCT05056727Phase 3Results posted
- Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson DiseaseTerminatedNCT05047523Phase 3Results posted
- A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT05019521Phase 2Results posted
- Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin LymphomaCompletedNCT05008055Phase 2Results posted
- Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis BronchiectasisTerminatedNCT05006573Phase 3Results posted
- Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid TumoursActive, not recruitingNCT04999969Phase 2Results posted
- Ravulizumab Versus Placebo in Adult Participants With DermatomyositisTerminatedNCT04999020Phase 2/3Results posted
- Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With HyperkalaemiaTerminatedNCT04997161Phase 4Results posted
- Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior RegimensCompletedNCT04989816Phase 2Results posted
- Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%CompletedNCT04986202Phase 2/3Results posted
- Study of ALXN1850 in Participants With Hypophosphatasia (HPP)CompletedNCT04980248Phase 1Results posted
- Phase II/III Study of AZD2816, for the Prevention of COVID-19 in AdultsCompletedNCT04973449Phase 2/3Results posted
- A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With HyperlipidaemiaCompletedNCT04964557Phase 2Results posted
- Technology-Assisted Cholesterol Trial in Consumers (TACTiC)CompletedNCT04964544Phase 3Results posted
- Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)CompletedNCT04931563Phase 3Results posted
- Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell LymphomaCompletedNCT04930536Phase 4Results posted
- Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform NeurofibromasActive, not recruitingNCT04924608Phase 3Results posted
- US PRECISION Implementation StudyCompletedNCT04891978Not applicableResults posted
- Managing Asthma Patients With AMAZE™: A Novel Disease Management PlatformCompletedNCT04868500Not applicableResults posted
- Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesTerminatedNCT04865419Phase 1Results posted
- Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal PolyposisCompletedNCT04851964Phase 3Results posted
- Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)TerminatedNCT04847232Phase 3Results posted
- Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese AdultsCompletedNCT04840849Phase 1Results posted